Literature DB >> 16302846

Side-effects of L-dopa on venous tone in Parkinson's disease: a leg-weighing assessment.

Jean-Pierre Wolf1, Malika Bouhaddi, Francis Louisy, Andrei Mikehiev, Laurent Mourot, Sylvie Cappelle, Fabrice Vuillier, Pierre Andre, Lucien Rumbach, Jacques Regnard.   

Abstract

In the present study, the effects of L-dopa treatment on cardiovascular variables and peripheral venous tone were assessed in 13 patients with Parkinson's disease (PD) with Hoehn and Yahr stages 1-4. Patients were investigated once with their regular treatment and once after 12 h of interruption of L-dopa treatment. L-Dopa intake significantly reduced systolic and diastolic blood pressure, heart rate and plasma noradrenaline and adrenaline in both the supine and upright (60 degrees ) positions. A significant reduction in stroke volume and cardiac output was also seen with L-dopa. The vascular status of the legs was assessed through thigh compression during leg weighing, a new technique developed in our laboratory. Healthy subjects were used to demonstrate that this technique provided reproducible results, consistent with those provided by strain gauge plethysmography of the calf. When using this technique in patients with PD, L-dopa caused a significant lowering of vascular tone in the lower limbs as shown, in particular, by an increase in venous distensibility. Combined with the results of the orthostatic tilting, these findings support that the treatment-linked lowering of plasma noradrenaline in patients with PD was concomitant with a significant reduction in blood pressure, heart rate and vascular tone in the lower limbs. These pharmacological side-effects contributed to reduce venous return and arterial blood pressure which, together with a lowered heart rate, worsened the haemodynamic status.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16302846     DOI: 10.1042/CS20050247

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  6 in total

1.  Orthostatic hypotension in Parkinson disease: how much you fall or how low you go?

Authors:  Jose-Alberto Palma; Juan Carlos Gomez-Esteban; Lucy Norcliffe-Kaufmann; Jose Martinez; Beatriz Tijero; Koldo Berganzo; Horacio Kaufmann
Journal:  Mov Disord       Date:  2015-02-12       Impact factor: 10.338

2.  Effects of levodopa therapy on global left ventricular systolic function in patients with Parkinson disease.

Authors:  Zeki Yüksel Günaydın; Osman Bektaş; Ahmet Karagöz; Fahriye Feriha Özer
Journal:  Wien Klin Wochenschr       Date:  2016-06-24       Impact factor: 1.704

Review 3.  Orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism.

Authors:  Seyed-Mohammad Fereshtehnejad; Johan Lökk
Journal:  Parkinsons Dis       Date:  2014-02-02

Review 4.  Cardiovascular/Stroke Risk Stratification in Parkinson's Disease Patients Using Atherosclerosis Pathway and Artificial Intelligence Paradigm: A Systematic Review.

Authors:  Jasjit S Suri; Sudip Paul; Maheshrao A Maindarkar; Anudeep Puvvula; Sanjay Saxena; Luca Saba; Monika Turk; John R Laird; Narendra N Khanna; Klaudija Viskovic; Inder M Singh; Mannudeep Kalra; Padukode R Krishnan; Amer Johri; Kosmas I Paraskevas
Journal:  Metabolites       Date:  2022-03-31

5.  Orthostatic stability with intravenous levodopa.

Authors:  Shan H Siddiqi; Mary L Creech; Kevin J Black
Journal:  PeerJ       Date:  2015-08-27       Impact factor: 2.984

6.  Subthalamic nucleus stimulation and levodopa modulate cardiovascular autonomic function in Parkinson's disease.

Authors:  Kai Li; Rocco Haase; Heinz Rüdiger; Manja Reimann; Heinz Reichmann; Martin Wolz; Tjalf Ziemssen
Journal:  Sci Rep       Date:  2017-08-01       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.